Please use this identifier to cite or link to this item:
|Title:||New insights into the role of PML in tumour suppression|
Ferguson, Brian J.
Wyllie, A. H.
|Publisher:||The Nature Publishing Group|
|Citation:||Cell Research, 2008, 18 (6), pp. 622-640|
|Abstract:||The PML gene is involved in the t(15;17) translocation of acute promyelocytic leukaemia (APL), which generates the oncogenic fusion protein PML-RAR. The PML protein localises to a subnuclear structure called the PML nuclear domain (PML-ND), of which PML is the essential structural component. In APL, PML-NDs are disrupted thus implicating these structures in the pathogenesis of this leukaemia. Unexpectedly, recent studies indicate that PML and the PML-ND play a tumour suppressive role in several different types of human neoplasms in addition to APL. Because of PML’s extreme versatility and involvement in multiple cellular pathways, understanding the mechanisms underlying its function, and therefore role in tumour suppression, have been a challenging task. In this review, we attempt to critically appraise the more recent advances in this field and propose new avenues of investigation.|
|Rights:||This is the author's final draft of the paper published as Cell Research 18 (6), pp. 622-640. The final version is available from www.nature.com. Doi: 10.1038/cr.2008.58|
|Appears in Collections:||Published Articles, MRC Toxicology Unit|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.